Working memory training for adult glioma patients: a proof-of-concept study.
Sarah Ellen BraunFarah J AslanzadehAutumn LanoyeStephanie Fountain-ZaragozaMark G MalkinAshlee R LoughanPublished in: Journal of neuro-oncology (2021)
CWMT was found to be safe and acceptable in adult patients with glioma. Enrollment, retention rates, and treatment adherence were all adequate and comparable to studies recruiting similar populations. Only moderate perceived benefit was reported despite demonstrated improvements in objectively-assessed WM. This may indicate that the time commitment and intervention intensity (5 weeks of 50-min training sessions on 5 days/week) outweighed the perceived benefits of the program. (Trial Registration Number: NCT03323450 registered on 10/27/2017).
Keyphrases
- working memory
- physical activity
- end stage renal disease
- social support
- depressive symptoms
- newly diagnosed
- mental health
- high intensity
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- clinical trial
- prognostic factors
- transcranial direct current stimulation
- virtual reality
- peritoneal dialysis
- attention deficit hyperactivity disorder
- healthcare
- health insurance
- type diabetes
- patient reported outcomes
- quality improvement
- metabolic syndrome
- adipose tissue
- combination therapy
- phase ii
- weight loss
- insulin resistance